OBGYN billing in Texas is under pressure from two converging revenue cycle problems in 2026, and practices across the state are seeing the financial impact in their monthly denial reports. The first is Modifier 25 — the most frequently audited modifier in the specialty, now carrying a new denial trigger tied to the 2026 G2211 conflict rule that most practices have not yet addressed. The second is a wave of state-level Medicaid postpartum policy changes that have created a 12-month coverage window in 49 states — most practices are not billing correctly because their workflows still reflect the old 60-day rule.
OB-GYN denial rates average between 18 and 22% nationally. In Texas, the combination of five competing Medicaid MCOs, aggressive commercial payer AI audits, and strict, timely filing windows pushes that number higher. Both issues are structural contributors — and both are correctable once the root cause is identified.
Modifier 25 in OB-GYN: Why Denials Are Rising — Especially in Texas
Modifier 25 signals that a provider performed a significant, separately identifiable evaluation and management (E/M) service on the same day as a procedure. In OB-GYN, this scenario is routine — a patient presents for a well-woman exam, and the provider also evaluates a new complaint; a patient comes in for an IUD insertion, and a separate clinical issue is addressed during the same visit. Both services are legitimately billable, but only with Modifier 25 correctly applied to the E/M.
In 2026, CMS identified Modifier 25 as a primary target for Targeted Probe and Educate (TPE) audits — alongside Modifiers 59 and 24. For OB-GYN billing in Texas, this matters acutely because the state’s five Medicaid MCOs and multiple dominant commercial payers each apply different same-day billing rules. Payer algorithms now flag practices where the modifier appears on nearly every procedure-day encounter, treating it as systematic misuse rather than clinical judgment. The financial risk runs in both directions: missing the modifier loses legitimate revenue, while applying it without sufficient documentation creates audit and recoupment exposure.
New in 2026 — the G2211 conflict. CMS guidelines prohibit billing the G2211 complexity add-on on the same day as an E/M that carries Modifier 25 for a minor procedure with a 0-day global period. OB-GYN practices that routinely bill G2211 on office visits that also include colposcopy, IUD insertion, LEEP, or cryotherapy are generating systematic denials on previously clean encounters as of January 1, 2026.
The three Modifier 25 errors that drive the most OB-GYN denials
- Missing modifier on same-day preventive and problem-focused visits. When a well-woman exam leads the provider to evaluate and manage a separate problem, both the preventive code and the problem-focused E/M are billable — but only with Modifier 25 on the E/M. Without it, payers bundle and deny the charge for the problem visit. This hits Florida Blue, Humana, Aetna, and UnitedHealthcare claims hardest and is the most consistent source of Modifier 25 revenue loss in OB-GYN.
- Inadequate documentation behind the modifier. Modifier 25 is won or lost in the clinical note. The note must show that the E/M involved history, examination, or clinical decision-making beyond the procedure’s pre-service assessment. A generic notation that the patient “was also evaluated” does not survive a payer audit.
- Global period violations. Billing a problem-focused E/M with Modifier 25 during the post-op global period of a recent gynecologic procedure — without clearly documenting an unrelated new problem — is a frequent denial and audit red flag, particularly for practices with high laparoscopy, hysterectomy, or colposcopy volumes.
State-by-State Medicaid Postpartum Coverage: What Changed and What It Means for OB-GYN Billing
Medicaid finances approximately 4 in 10 births in the United States. Federal law historically required states to cover postpartum patients for only 60 days after delivery. The American Rescue Plan Act of 2021 gave states the option to extend that window to 12 months, made permanent by the Consolidated Appropriations Act of 2023.
As of 2026, 49 states and Washington, D.C., have adopted the 12-month extension. Wisconsin passed its extension by a 95-1 vote in the Assembly in early 2026. Arkansas is the only remaining state that has not adopted it and retains the original 60-day coverage period.
For OB-GYN practices, this means postpartum visits, contraceptive counseling, mental health screenings, and gynecologic care between 60 days and 12 months postpartum are now Medicaid-covered in nearly every state — but only if the billing workflow reflects the extended window.
The most common failure pattern: A practice verifies Medicaid eligibility at the 6-week postpartum visit, confirms active coverage, and assumes it holds. When the patient returns at month 3, 6, or 9, no one re-verifies. The claim denies — or goes to the wrong plan. The coverage was there. The billing workflow was not.
Postpartum Medicaid by state — billing implications
| State(s) | Coverage | Key billing consideration |
| California, New York, Texas, Florida, Illinois, Pennsylvania, Ohio, Michigan, Georgia, North Carolina | 12 months — full | Highest Medicaid birth volumes nationally — the postpartum billing gap has the largest dollar impact here. Multiple competing MCOs in each state; the plan at delivery often differs from the plan at month 6 or 9. Re-verify MCO assignment at every postpartum visit through month 12. |
| Virginia, Maryland, Massachusetts, Colorado, Washington, Oregon, Minnesota, New Jersey, Connecticut, Louisiana, Tennessee, South Carolina, Indiana, Alabama, Hawaii, Kentucky, Maine, New Mexico, Arizona, Oklahoma, North Dakota, West Virginia, Rhode Island, Delaware, South Dakota, Nebraska, Montana, Mississippi, Idaho, Nevada, Wyoming, Utah, Missouri, Alaska, Vermont, New Hampshire, Iowa, Kansas | 12 months — full | Full 12-month extension adopted. Most operate through Medicaid managed care organizations. The applicable MCO may change between months 2 and 12 — identify and bill the correct plan at each postpartum visit rather than defaulting to the delivery-period plan. |
| Wisconsin | 12 months — adopted 2026 | Wisconsin passed its extension in early 2026 (95-1 Assembly vote). Confirm the effective date with Wisconsin Medicaid before applying 12-month billing assumptions to Wisconsin Medicaid postpartum patients. |
| Arkansas | 60 days only | The only state without the 12-month extension. Postpartum Medicaid coverage ends at 60 days. Do not apply extended-coverage billing assumptions to Arkansas Medicaid patients. |
In managed care states — including California, Texas, Florida, New York, Illinois, Ohio, Michigan, and most others — postpartum patients can be enrolled in different MCOs at different points in the coverage year. Billing the wrong MCO is a silent, systemic source of denial that compounds across a high-volume postpartum panel without triggering a clear error message.
Why Texas OB-GYN Practices Are Among the Hardest Hit
Texas combines all the factors that drive Modifier 25 and postpartum Medicaid billing problems — and concentrates them in a single state. It has the highest raw number of OB-GYN practices in the country, one of the largest Medicaid birth volumes, the most fragmented managed care market of any large state, and some of the strictest timely filing windows in the country. The result is that Texas OB-GYN physicians face both issues simultaneously at a scale that most other states do not.
Modifier 25 in Texas
Texas’s dominant commercial payers — Blue Cross Blue Shield of Texas, Aetna, Cigna, UnitedHealthcare, and Humana — each apply different same-day billing rules for combinations of preventive and problem-focused visits. What is clear as a valid Modifier 25 claim at BCBS Texas may be denied at Aetna for the same encounter type and documentation. Texas OB-GYN practices serving patients across multiple commercial payers need plan-specific Modifier 25 protocols — not a single modifier rule applied uniformly. Without them, the practice is generating preventable denials at one or more payers on every high-volume procedure day.
The 2026 G2211 conflict rule compounds this further in Texas because IUD insertion, colposcopy, and LEEP are high-volume in-office procedures across Texas women’s health practices. Every encounter on which the provider bills G2211 and also performs one of these procedures now triggers a potential denial under the new CMS rule — unless the claim is structured correctly for that encounter type.
Postpartum Medicaid in Texas
Texas Medicaid operates through five competing managed care organizations: Molina Healthcare, Superior HealthPlan, UnitedHealthcare Community Plan, Driscoll Health Plan, and CHIP Perinate. Each applies different prior-authorization requirements, covered-procedure definitions, and postpartum eligibility windows. A postpartum Medicaid patient in Houston may be enrolled in Superior HealthPlan at delivery and Molina by month 6, and the billing team may not be notified of the change until a claim is denied.
Texas also enforces strict 90-day timely filing windows for most Medicaid MCOs. When a claim is returned for a missing document or incorrect MCO, the 90-day clock resets differently per plan — and many corrected postpartum claims arrive after the filing window has closed, converting recoverable revenue into permanent write-offs.
Texas-specific billing action items for OB-GYN practices: Maintain a payer-specific Modifier 25 protocol for each of the five major Texas Medicaid MCOs and all dominant commercial plans. Run real-time MCO eligibility verification at every postpartum visit — not just at delivery. Track MCO-specific filing deadlines, not as a uniform rule. And update the G2211 claim logic to screen for a 0-day global period conflict before submission for any procedure-day encounter.
What a Revenue Diagnostic Finds in a Typical OB-GYN Practice
When MBC audits OBGYN billing in Texas and across other high-volume states, these patterns appear consistently regardless of practice size:
- Modifier 25 missing on same-day preventive and problem-focused visit combinations — denying most commonly with Florida Blue, Humana, Aetna, UnitedHealthcare, and state Medicaid MCOs in Florida, Texas, California, New York, and Georgia
- G2211 billed on procedure days without accounting for the 2026 Modifier 25 conflict rule — generating denials on encounter types that billed cleanly before January 1
- Postpartum Medicaid claims were denied between months 2 and 12 in California, Florida, Texas, New York, Georgia, North Carolina, and other full-extension states — eligibility was not re-verified at extended-window visits
- Wrong MCO billed for postpartum visits in Illinois, Ohio, Michigan, and other multi-MCO managed care states — the patient’s plan changed mid-postpartum-year, and the billing record was not updated.
- No structured Modifier 25 audit in the past 12 months — the practice has no visibility into whether its modifier application rate falls within or outside payer audit thresholds
A Revenue Diagnostic identifies exactly where these gaps exist in your practice — by payer, procedure type, and postpartum patient volume — using your actual claims data. It takes about 15 minutes and carries no cost or commitment. Request yours here.
Modifier 25 denials and uncaptured postpartum Medicaid revenue repeat on every claim cycle until the billing workflow is corrected. Whether you’re managing OBGYN billing in Texas or any other state, MBC’s Revenue Diagnostic shows exactly where your practice is losing money — and what recovering it is worth.
Frequently Asked Questions
Modifier 25 is required when a provider performs a significant, separately identifiable E/M service on the same day as a procedure. In OB-GYN — and particularly in OBGYN billing in Texas, where same-day visit combinations are common across high-volume practices — the most frequent scenarios are: a well-woman exam during which the provider evaluates an unrelated medical problem; an office procedure (IUD insertion, colposcopy, LEEP, biopsy) during which a distinct E/M is performed for a separate clinical concern; and a postpartum visit addressing a new acute complaint beyond the routine assessment. The clinical note must document separate history, examination, and medical decision-making beyond the procedure’s pre-service evaluation — not just a generic reference to additional evaluation.
Two concurrent factors are driving the increase. First, CMS designated Modifier 25 as a primary Targeted Probe and Educate (TPE) audit target in 2026 — payer systems are actively flagging practices where the modifier appears on nearly every procedure-day encounter. Second, the 2026 G2211 conflict rule prohibits billing the G2211 complexity add-on on the same day as an E/M with Modifier 25 for a minor procedure with a 0-day global period. OB-GYN practices that added G2211 to their standard billing workflow in 2024 or 2025, without updating their workflows for this rule, are generating systematic denials on previously clean encounters.
As of 2026, 49 states and Washington, D.C., have implemented the 12-month postpartum Medicaid extension. This includes all major OB-GYN markets: California, New York, Texas, Florida, Illinois, Pennsylvania, Ohio, Michigan, Georgia, North Carolina, Virginia, Maryland, Massachusetts, Colorado, Washington, Oregon, Minnesota, New Jersey, Connecticut, Louisiana, Tennessee, South Carolina, Indiana, Alabama, Hawaii, Kentucky, Maine, New Mexico, Arizona, Oklahoma, Wisconsin (newly adopted in early 2026), and all remaining states except Arkansas. Arkansas is the only state that has not adopted the extension and retains the 60-day postpartum coverage window.
In managed care states — including California, Texas, Florida, New York, Illinois, Ohio, Michigan, and most large states — postpartum patients may be enrolled in different Medicaid MCOs at different points in the 12-month coverage year. The plan covering the patient at delivery may not be the same as the plan at months 6 or 9. Billing the wrong MCO results in an avoidable denial, even when coverage is active. OB-GYN practices must verify the current MCO assignment at every postpartum visit throughout the 12-month window — not default to the delivery-period plan for all subsequent visits.
Yes — but only when Modifier 25 is correctly appended to the problem-focused E/M and the documentation supports a genuinely separate clinical evaluation. The problem addressed must be distinct from the scope of the preventive visit, and the note must clearly reflect separate history, exam findings, and medical decision-making for that concern. Without Modifier 25, payers, including Florida Blue, Humana, Aetna, and UnitedHealthcare, will bundle the problem-focused E/M into the preventive code and deny the separate charge.
OBGYN Billing Services in Texas
Phone: 888-357-3226Fax: 888-316-4566
Email: sales@medicalbillersandcoders.com